Despite the politics involved in healthcare, it seems unlikely that the industry to going to stop its migration toward more accountability for quality, said Michael Kolodziej, MD, national medical director of managed care strategy at Flatiron Health.
Despite the politics involved in healthcare, it seems unlikely that the industry to going to stop its migration toward more accountability for quality, said Michael Kolodziej, MD, national medical director of managed care strategy at Flatiron Health.
Transcript (slightly modified)
Do you think the decision by HHS Secretary Tom Price, MD, to back away from mandatory bundled payments will affect the industry’s transition to value-based payments?
Ironically, Dr Price’s biggest bone was with the mandatory bundle, and he is, of course, an orthopedist.
I think in oncology, because the OCM [Oncology Care Model] was a voluntary model, people tell me that it’s very popular in Washington, DC. People really like it; it is a much more patient-centric model as opposed to a purely economic model. I believe we will definitely see the OCM survive—there may be tweaks.
I think the real question is—and if you know this please share it with me—in 3 years, where does the administration sit in terms of what happens in healthcare? You know, this last week we had the introduction of the Medicare for All stuff, I think pretty much everybody believes that that’s posturing and is not going to go anywhere. But, I think the idea that we are going to successfully migrate to some sort of accountability for quality and rewarding financial equality—I don’t think we’re going back from that. I think we’re going forward. MACRA [Medicare Access and CHIP Reauthorization Act] may be a clumsy attempt at it, but I think that MACRA is a pretty good indicator that this is going to affect every nook and cranny of American medicine.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
CMS is highly likely to negotiate the price of the obesity medication semaglutide in the coming years; many health care providers are trying to determine whether their cyberattack insurance will help cover their losses after the Change Healthcare hack; the US life expectancy increased for the first time in 2 years.
Read More